Confirmed Speakers & Talk Titles

You want to talk at the GQ2023 event?
   Please contact Michael W. Pfaffl  GeneQuan.Physio@ls.tum.de


Talk Sessions:


Talks will be held in
lecture hall 14  (HS14)
and
lecture hall 15  (HS15)
at
TUM School of Life Sciences
Technical University of Munich
School of Life Sciences
Weihenstephan-Campus
85354 Freising
Germany
Please register and submit your TALK & POSTER abstracts  via ConfTool registration & submission platform
=> https://www.conftool.com/GQ2023/   Submission deadline is postponed to 15th January 2023



Sars-Cov-2 Quantification
-- MIQE, Pitfalls and Solutions

Title
References
JIM HUGGETT
PhD, Science Fellow, UK National Measurement Laboratory, Nucleic Acid Metrology, LGC, Teddington, UK
visiting Professor, Analytical Microbiology, University of Surrey, UK


How to approach diagnosing the next pandemic. A lesson from Covid-19.

CARL WITTWER
Professor, Department of Pathology, University of Utah, US
Adjunct Professor, Biomedical Engineering, University of Utah, US

At-home PCR testing for SARS-CoV-2
MAURICE JB van den HOFF
PhD, AmsterdamUMC, Location AMC, Department Medical Biology, Meibergdreef 15, 1105AZ Amsterdam, The Netherlands

Reliable quantification of Sars-Cov-2 in standard clinical samples is not possible
CORINNA HOLETSCHEK
Environmental Medicine, Faculty of Medicine, University of Augsburg, Germany; Institute of Environmental Medicine, Helmholtz Center Munich, Germany; Chair of Environmental Medicine, Technical University of Munich, Germany

Sars-CoV-2 RNA vs Antigen Kinetics in Different Compartments
invited by
AGNES MEIDERT
Department of Anesthesiology, Biomarker Research Lab, LMU University Hospital Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany

Extracellular vesicles in Covid-19 pneumonia and progression to acute respiratory failure

Spatial-Transcriptomics



RAFFAELE A. CALOGERO
Molecular Biotechnology Center, University of Torino, Torino, Italy

Limits and strength of Visium spatial transcriptomics platform


MATHIAS HOLPERT
PhD, Principle Product Application Scientist, NanoString Technologies, Inc.

Spatial transcriptomics – studies on the single cell and functional level of tissue
AHMAD AL ALWASH
Predoctoral Fellow in Jan’s Korbel lab at the Genome Biology Unit, EMBL, Heidelberg, Germany


Spatial Multi-omics Analysis of The Tumor Microenvironment In Colon Cancers

MARC REUDELSTERZ
Vizgen Inc,
USA

Molecular Atlassing with MERSCOPE Reveals the Spatial Organization of Mouse and Human Tissues


LUKAS VALIHRACH
Senior Scientist, Laboratory of Gene Expression, Institute of Biotechnology CAS @ BIOCEV, CzechBIO, The Technology Centre CAS, Czech Republic


Patiotemporal dynamics of ischemic brain injury resolved at single-cell level


Multi-Omics Biomarkers




PIETER MESTDAGH
CellCarta, Technologiepark 3, B-9052 Zwijnaarde, Belgium
Prof. at Center for Medical Genetics,
University of Ghent, Belgium

Leveraging tumor RNA-sequencing data to quantify TMB, MSI and TIL for immune checkpoint inhibition therapy response prediction


ROBERT LOEWE
CEO, GeneSurge GmbH, Munich, Germany

Real world multi-omics not lost in clinical translation

MARKUS LIST
Head of "Big Data in BioMedicine", Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Germany


Competing endogenous RNAs as biomarkers of miRNA activity
PHILIPP BECKER
PhD, Singleron Biotechnologies, Cologne, Germany

Multi-verse in a nutshell: Advanced single cell multi-omics technologies




SARANTIS CHLAMYDAS
Phd, Scientific Director, MultiOmics, Olink Proteomics, Uppsala, Sweden

Novel NGS-based proteomics revolutionizes biomarker identification in liquid biopsies



Liquid Biopsy & Circulating Nucleic Acids




KLAUS PANTEL
Director of the Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany


Liquid Biopsy -- From Discovery to Clinical Implementation

JO VANDESOMPELE
Professor at Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, University of Ghent, Belgium


Performance of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study


ADAM S CORNER
PhD, Market Development Manager, EMEA & APAC, Digital Biology Group, Bio-Rad Laboratories, USA
Maximizing metastasis insights: Using an integrated workflow approach to achieve efficient CTC enrichment with targeted enumeration for versatile downstream applications


STEFAN HOLDENRIEDER
Prof, MD, Director of Institute of Laboratory Medicine, German Heart Centre Munich, Technical University of Munich, Germany

New perspectives for liquid profiling of circulating nucleic acids in clinical diagnostics


NIELS PALLISGAARD
Professor, Department of Science and Environment, Molecular and Medical Biology, Sjællands Universitetshospital Roskilde, Patologiafdelingen, Roskilde, Denmark


Systemic Alterations in the Systemic Inflammatory Response and Circulating Cell-free DNA in Relation to Stent Placement

invited by


STEFANIA CRUCITTA
PhD, Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Comparison Of Two Digital PCR Systems For The Analysis Of Liquid Biopsy Samples Of Patients Affected By Lung And Colorectal Cancer


invited by
ANDERS STAHLBERG
Prof. and Senior Scientist, Sahlgrenska Cancer Center, University of Gothenburg, Sweden

Digital sequencing using liquid biopsies: clinical and technical aspects


Digital-PCR


JIM HUGGETT
PhD, Science Fellow, UK National Measurement Laboratory, Nucleic Acid Metrology, LGC, Teddington, UK
visiting Professor, Analytical Microbiology, University of Surrey, UK


10 years Of digital MIQE; What have we learned?

MATTHIJS VYNCK
PhD, Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Faculty of Veterinary Medicine, Ghent University, Belgium

Achieve high-level multiplexing using 6-color digital PCR with robust assay designs and partition classification


MEGAN CLEVELAND
NIST, Monrovia, MD, USA

Accuracy of Digital Polymerase Chain Reaction

GARY PESTANO
PhD, Chief Development Officer, Biodesix Inc., Boulder, Colorado, USA

Development of Advanced Droplet Digital PCR Applications for the Clinical Lab
invited by
VALERIE TALY
PhD, group leader, INSERM Université Paris Descartes UMRS1147, CNRS SNC 5014, Equipe Labellisée Ligue nationale contre le cancer (LNCC), France


Digital PCR for the follow-up of patient with cancer

ROBERT SJÖBACK
Head of R&D, TATAA Biocenter AB, Göteborg, Sweden

Design and Validation of Precision dPCR assays



MicroGenomics: EV & Single-Cells Diagnostics




MIKAEL KUBISTA
Prof. of  Biotechnology, BTU, Czech Academy of Sciences & TATAA Biocenter, Sweden


Applications of Two-Tailed PCR for Precision Diagnostics


PAMELA PINZANI
Associate Professor of Clinical Biochemistry Clinical and Molecular Biochemistry Laboratory Careggi University Hospital, Department of Biomedical, Experimental and Clinical Sciences University of Florence, Italy


Molecular characterization of single Circulating Tumor Cells -- challenges and promise for translation to the clinic


THOMAS KRONEIS
Division of Cell Biology, Histology & Embryology, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Austria
Total Quality Management, Center for Biomarker Research in Medicine GmbH, Graz, Austria


On the analysis of microchimerism
RADEK SINDELKA
PhD, Gene Expression Laboratory, IBT, Institute of Biotechnology CAS, Vestec, Czech Republic

Healing as a key phase of regeneration studied by bulk, single-cell and spatial transcriptomic analyses


Non-coding RNAs
microRNA, small RNAs, tRFs, piRNAs, lnc-RNAs




MICHAEL W. PFAFFL
Prof. of Molecular Physiology, Animal Physiology & Immunology, TUM School of Life Sciences, Freising Weihenstephan, Germany


A development and analysis pipeline for microRNA biomarker signatures in molecular diagnostics based on circulating EVs




ERIC JAMES DE BONY DE LAVERGNE
Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium, Biogazelle, Zwijnaarde, Belgium

High-throughput CRISPR-interference screening platform to study lncRNA functions through serial cellular and molecular phenotypin


Next Generation Sequencing




STEFAN FILGES
CTO, Simsen Diagnostics, Sahlgrenska Science Park, Gothenburg, Sweden


Tumour-guided Personalised Sequencing Assays For ctDNA Detection



KLAUS NEUHAUS
PhD, Head of Core Facility Microbiome, ZIEL Institute for Food & Health, Technische Universität München, Germany

Quantification with Spike DNA and Common Pitfalls of 16S rRNA Gene Amplicon Data Analysis in Microbiome Research


SUBRATA PANJA
Quantabio, 100 Cummings Center Suite 407J, Beverly, MA, USA
Significant Improvements To PCR Amplification Enables Better Performance For A Multitude Of Next Generation Sequencing Applications: Library Amplification With Fast, Processive, Higher-Fidelity And Inhibitor Tolerant PCR Master Mixes In The New Era Of NGS


NISH KUMAR
Bio-Rad Laboratories Inc., Hercules CA, USA
Simultaneous Interrogation of Small RNAs and Long RNAs from archival breast cancer FFPE samples using Next Generation Sequencing (NGS)


JORDAN MOORE
Director, Applications, EMEA,
Standard Biotools, Lyon, France

Setting the new benchmarks in automated and cost-effective qPCR and NGS assays -- Meet the Biomark X and Juno



KRYSTYNA NAHLIK
PhD, LGC Clinical Diagnostics, Wetzlar, Germany

Essential Factors Affecting the Assessment of Homologous Recombination Deficiency by NGS

invited by
Data Analysis, Algorithms and more




TOBIAS ÖSTERLUND
Bioinformatician, Gothenburg University and Sahlgrenska University Hospital, Sweden

Bioinformatics tools for ultra-sensitive sequencing data using unique molecular identifiers
DAVID LANGENBERGER
CEO, PhD, ecSeq Bioinformatics GmbH, Leipzig, Germany


Gene Fusion Detection - more complex than you might assume

AMIN FOROOTAN
CEO, MultiD Göteborg, Sweden
MIKAEL KUBISTA
CEO, TATAA Biocenter, Göteborg, Sweden

Genex For The Analysis Of QPCR And DPCR Data In Regulated Environments
logo MultiD
Advanced Molecular Dx in Life Science




STEPHEN A. BUSTIN
Prof. of Molecular Medicine, Postgraduate Medical Institute, Faculty of Health, Social Care & Education, Anglia Ruskin University, UK

RT-ePCR: A paradigm shift for molecular diagnostics

VANESSA GEBAUER
PhD, Head of Technical Operations, IMGM Laboratories GmbH, Munich, Germany

Putting Ideas Into Action - How IMGM Can Accelerate Your Research

CHRISTIAN SIGL
CEO, capsitec GmbH, Germany
Programmable Antiviral Platform Based On DNA Nanotechnology – The VIRUS TRAP


MATTHIEU LEWIS
PhD, Senior Market Strategy Manager, Molecular Diagnostics at Takara Bio Europe, St.-Germain-en-Laye, Île-de-France, France


How Research Tools and Enzymes Became Fundamental Components of Molecular Diagnostic Solutions
ABEL BRONKHORST
PhD, Institute of Laboratory Medicine, German Heart Centre Munich, Technical University of Munich, Germany

Biological, structural and functional aspects of circulating nucleic acids


ANNE LOUISE WYLLIE
Research Scientist in Epidemiology (Microbial Diseases), Yale School of Public Health, New Haven, USA

Simplified Testing for Public Health Impact




PATRICK GÜRTLER
PhD, Bavarian Health and Food Safety Authority, Molecular Biology Unit, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL), Oberschleissheim, Germany

Detection of mutations generated by genome editing - activities of the § 28b GenTG working group


ERIK WENDLANDT
Manager of Core and qPCR Applications Development, IDT, USA


Novel identification in diverse sample types through direct amplification


RASMUS KOEFOED PETERSEN
R&D, Pentabase, Odense, Denmark

A novel qPCR technology for direct quantification of methylations in untreated DNA




BRIGITTA SAUL
PhD, Promega Corporation, Madison, WI, USA

Design of qPCR assays including standards and controls for pathogen testing in wastewater


MIQE & Quality Management & Standardisation Strategies in Molecular Diagnostics




JAN RUIJTER
PhD, Department of Medical Biology, Amsterdam University Medical Center (UMC), The Netherlands

One more time: do not ignore the amplification efficiency!
JAN HELLEMANS
CTO, CellCarta, Technologiepark 3, B-9052 Zwijnaarde, Belgium

Assay validation: the minimum for research purposes or in depth for clinical trials



JENS BJÖKMAN
President, Head of Commissioned Services, TATAA Biocenter AB, Göteborg, Sweden

Lifting a nucleic acid service lab to GLP compliance


DAVE SCHUSTER
R&D, Quantabio, Beverly, MA, USA

QScript Ultra RT: A Next-Generation Reverse Transcriptase Platform To Break Cold-Chain Barriers And Democratize State Of The Art RNA Quantification Tools


ANDREAS UNTERGASSER
Zentrum für Molekulare Biologie der Universität Heidelberg
Im Neuenheimer Feld 329, D-69120 Heidelberg, Germany

Absolute quantification of estimated copy number without a standard curve



Please direct your enquiry to our scientific organisation team, headed by Michael W. Pfaffl  GeneQuan.Physio@ls.tum.de
©  2004-2023